Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

46,642 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Efficacy and safety of adjuvant post-surgical therapy with imatinib in gastrointestinal stromal tumor patients with high risk of recurrence: interim analysis from a multicenter prospective clinical trial].
Zhan WH, Wang PZ, Shao YF, Wu XT, Gu J, Li R, Wan DS, Ding KF, Shi YQ, Yu JR, Lu HS, Zou XM, Bi JW, Sun YH, Lu YF, Chen DD, Zhang XH. Zhan WH, et al. Among authors: yu jr. Zhonghua Wei Chang Wai Ke Za Zhi. 2006 Sep;9(5):383-7. Zhonghua Wei Chang Wai Ke Za Zhi. 2006. PMID: 17043955 Chinese.
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial.
Zhang X, Liang H, Li Z, Xue Y, Wang Y, Zhou Z, Yu J, Bu Z, Chen L, Du Y, Wang X, Wu A, Li G, Su X, Xiao G, Cui M, Wu D, Chen L, Wu X, Zhou Y, Zhang L, Dang C, He Y, Zhang Z, Sun Y, Li Y, Chen H, Bai Y, Qi C, Yu P, Zhu G, Suo J, Jia B, Li L, Huang C, Li F, Ye Y, Xu H, Wang X, Yuan Y, E JY, Ying X, Yao C, Shen L, Ji J; RESOLVE study group. Zhang X, et al. Among authors: yu p, yu j. Lancet Oncol. 2021 Aug;22(8):1081-1092. doi: 10.1016/S1470-2045(21)00297-7. Epub 2021 Jul 9. Lancet Oncol. 2021. PMID: 34252374 Clinical Trial.
Clinicopathologic Characteristics and Prognosis of PDGFRA-Mutant Gastrointestinal Stromal Tumors: A Large-Scale, Multi-Institutional, Observational Study in China.
Zhang P, Wang M, Li J, Gao X, Zhang B, Liang H, Zhou Y, Liao G, Feng F, Zhou Y, Yu J, Zhang J, Zhou Y, Ye Y, Chen J, Zhao Q, Shen K, Cao H, Tao K. Zhang P, et al. Among authors: yu j. Adv Ther. 2022 Jun;39(6):2920-2931. doi: 10.1007/s12325-022-02115-3. Epub 2022 Apr 24. Adv Ther. 2022. PMID: 35462602
Efficacy and Safety of Avapritinib in Treating Unresectable or Metastatic Gastrointestinal Stromal Tumors: A Phase I/II, Open-Label, Multicenter Study.
Li J, Zhang X, Deng Y, Wu X, Zheng Z, Zhou Y, Cai S, Zhang Y, Zhang J, Tao K, Cui Y, Cao H, Shen K, Yu J, Zhou Y, Ren W, Qu C, Zhao W, Hu J, Wang W, Yang J, Shen L. Li J, et al. Among authors: yu j. Oncologist. 2023 Feb 8;28(2):187-e114. doi: 10.1093/oncolo/oyac242. Oncologist. 2023. PMID: 36477870 Free PMC article. Clinical Trial.
[A Chinese multi-center study on the significance of monitoring imatinib plasma concentration in patients with gastrointestinal stromal tumor before and after administration].
Xu H, Ma L, Xu W, Guan W, Wang B, Li G, Miao Y, Li L, Chen H, Yu J, Wang Y, Sun L, Yang L, Zhang D, Li F, Zhi X, Wang J, Xu J, Xu Z. Xu H, et al. Among authors: yu j. Zhonghua Wei Chang Wai Ke Za Zhi. 2016 Nov 25;19(11):1271-1276. Zhonghua Wei Chang Wai Ke Za Zhi. 2016. PMID: 27928798 Chinese.
The prognostic value of neutrophil-lymphocyte ratio is superior to derived neutrophil-lymphocyte ratio in advanced gastric cancer treated with preoperative chemotherapy and sequential R0 resection: a 5-year follow-up.
Jin H, Sun J, Zhu K, Liu X, Zhang Q, Shen Q, Gao Y, Yu J. Jin H, et al. Among authors: yu j. Onco Targets Ther. 2017 May 22;10:2655-2664. doi: 10.2147/OTT.S135641. eCollection 2017. Onco Targets Ther. 2017. PMID: 28579803 Free PMC article.
46,642 results
You have reached the last available page of results. Please see the User Guide for more information.